Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25608
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBarthel, Henryk-
dc.contributor.authorSeibyl, John-
dc.contributor.authorLammertsma, Adriaan A-
dc.contributor.authorVillemagne, Victor L-
dc.contributor.authorSabri, Osama-
dc.date2020-05-15-
dc.date.accessioned2021-01-04T23:56:50Z-
dc.date.available2021-01-04T23:56:50Z-
dc.date.issued2020-08-
dc.identifier.citationJournal of Nuclear Medicine 2020; 61(8): 1105-1106en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/25608-
dc.language.isoeng
dc.titleExploiting the Full Potential of β-Amyloid and Tau PET Imaging for Drug Efficacy Testing.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Nuclear Medicineen
dc.identifier.affiliationDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germanyen
dc.identifier.affiliationMedicine (University of Melbourne)en
dc.identifier.affiliationInstitute for Neurodegenerative Disorders, New Haven, Connecticuten
dc.identifier.affiliationMolecular Imaging and Therapyen
dc.identifier.affiliationDepartment of Radiology and Nuclear Medicine, Vrije Universiteit University Medical Center, Amsterdam, The Netherlandsen
dc.identifier.doi10.2967/jnumed.119.228346en
dc.type.contentTexten
dc.identifier.pubmedid32414946
local.name.researcherVillemagne, Victor L
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptMolecular Imaging and Therapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

36
checked on Nov 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.